Form 4: Ardent Health Partners Director Acquires Restricted Stock Units

Robert Thomas Webb, a director at Ardent Health Partners, acquired 10,793 restricted stock units on December 12, 2024.

Summary

• Robert Thomas Webb, a director of Ardent Health Partners, acquired 10,793 restricted stock units on December 12, 2024.
• These restricted stock units vest in three equal installments annually starting December 12, 2025.
• The vesting is subject to pro-rata vesting if the director's service terminates under certain conditions related to the company's annual meeting of stockholders.
• Following the transaction, Mr. Webb beneficially owns 51,068 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock units to a director, which is generally positive for alignment of interests, but not a major event.

Positives

• The acquisition of restricted stock units aligns the director's interests with the long-term performance of the company.
• The vesting schedule encourages continued service by the director.

Risks

• The vesting of the restricted stock units is contingent on the director's continued service, which could be impacted by unforeseen circumstances.

Industry Context

This is a standard transaction for directors of publicly traded companies, often used as part of their compensation package to align their interests with shareholders.

Comparison to Industry Standards

• The vesting schedule of three equal annual installments is a common practice for restricted stock units granted to directors.
• Many companies in the healthcare sector use similar equity-based compensation to incentivize board members.

Stakeholder Impact

• The transaction aligns the director's interests with shareholders by tying a portion of their compensation to the company's stock performance.

Key Dates

Keywords

restricted stock units, director, beneficial ownership, stock vesting, Ardent Health Partners, ARDT